Request for Covid-19 Impact Assessment of this Report
The United States Biopharmaceutical Oral Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biopharmaceutical Oral Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Biopharmaceutical Oral Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biopharmaceutical Oral Drug Delivery players cover AbbVie, Amgen, Catalent, and Kemwell Bipharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Oral Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Normally Protein (Antibodies)
Nucleic Acids (DNA, RNA Or Oligonucleotides)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacy
Retail Pharmacy
Specialty Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie
Amgen
Catalent
Kemwell Bipharma
Pfizer
Novartis
Biocon
Sanofi
F. Hoffman-La Roche
Novo Nordisk
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharmaceutical Oral Drug Delivery Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biopharmaceutical Oral Drug Delivery by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biopharmaceutical Oral Drug Delivery by Country/Region, 2017, 2022 & 2028
2.2 Biopharmaceutical Oral Drug Delivery Segment by Type
2.2.1 Normally Protein (Antibodies)
2.2.2 Nucleic Acids (DNA, RNA Or Oligonucleotides)
2.3 Biopharmaceutical Oral Drug Delivery Sales by Type
2.3.1 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2022)
2.3.2 Global Biopharmaceutical Oral Drug Delivery Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biopharmaceutical Oral Drug Delivery Sale Price by Type (2017-2022)
2.4 Biopharmaceutical Oral Drug Delivery Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Specialty Pharmacy
2.5 Biopharmaceutical Oral Drug Delivery Sales by Application
2.5.1 Global Biopharmaceutical Oral Drug Delivery Sale Market Share by Application (2017-2022)
2.5.2 Global Biopharmaceutical Oral Drug Delivery Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biopharmaceutical Oral Drug Delivery Sale Price by Application (2017-2022)
3 Global Biopharmaceutical Oral Drug Delivery by Company
3.1 Global Biopharmaceutical Oral Drug Delivery Breakdown Data by Company
3.1.1 Global Biopharmaceutical Oral Drug Delivery Annual Sales by Company (2020-2022)
3.1.2 Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Company (2020-2022)
3.2 Global Biopharmaceutical Oral Drug Delivery Annual Revenue by Company (2020-2022)
3.2.1 Global Biopharmaceutical Oral Drug Delivery Revenue by Company (2020-2022)
3.2.2 Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Company (2020-2022)
3.3 Global Biopharmaceutical Oral Drug Delivery Sale Price by Company
3.4 Key Manufacturers Biopharmaceutical Oral Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biopharmaceutical Oral Drug Delivery Product Location Distribution
3.4.2 Players Biopharmaceutical Oral Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biopharmaceutical Oral Drug Delivery by Geographic Region
4.1 World Historic Biopharmaceutical Oral Drug Delivery Market Size by Geographic Region (2017-2022)
4.1.1 Global Biopharmaceutical Oral Drug Delivery Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biopharmaceutical Oral Drug Delivery Annual Revenue by Geographic Region
4.2 World Historic Biopharmaceutical Oral Drug Delivery Market Size by Country/Region (2017-2022)
4.2.1 Global Biopharmaceutical Oral Drug Delivery Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biopharmaceutical Oral Drug Delivery Annual Revenue by Country/Region
4.3 Americas Biopharmaceutical Oral Drug Delivery Sales Growth
4.4 APAC Biopharmaceutical Oral Drug Delivery Sales Growth
4.5 Europe Biopharmaceutical Oral Drug Delivery Sales Growth
4.6 Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales Growth
5 Americas
5.1 Americas Biopharmaceutical Oral Drug Delivery Sales by Country
5.1.1 Americas Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022)
5.1.2 Americas Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022)
5.2 Americas Biopharmaceutical Oral Drug Delivery Sales by Type
5.3 Americas Biopharmaceutical Oral Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical Oral Drug Delivery Sales by Region
6.1.1 APAC Biopharmaceutical Oral Drug Delivery Sales by Region (2017-2022)
6.1.2 APAC Biopharmaceutical Oral Drug Delivery Revenue by Region (2017-2022)
6.2 APAC Biopharmaceutical Oral Drug Delivery Sales by Type
6.3 APAC Biopharmaceutical Oral Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biopharmaceutical Oral Drug Delivery by Country
7.1.1 Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022)
7.1.2 Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022)
7.2 Europe Biopharmaceutical Oral Drug Delivery Sales by Type
7.3 Europe Biopharmaceutical Oral Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biopharmaceutical Oral Drug Delivery by Country
8.1.1 Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022)
8.2 Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales by Type
8.3 Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biopharmaceutical Oral Drug Delivery
10.3 Manufacturing Process Analysis of Biopharmaceutical Oral Drug Delivery
10.4 Industry Chain Structure of Biopharmaceutical Oral Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biopharmaceutical Oral Drug Delivery Distributors
11.3 Biopharmaceutical Oral Drug Delivery Customer
12 World Forecast Review for Biopharmaceutical Oral Drug Delivery by Geographic Region
12.1 Global Biopharmaceutical Oral Drug Delivery Market Size Forecast by Region
12.1.1 Global Biopharmaceutical Oral Drug Delivery Forecast by Region (2023-2028)
12.1.2 Global Biopharmaceutical Oral Drug Delivery Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biopharmaceutical Oral Drug Delivery Forecast by Type
12.7 Global Biopharmaceutical Oral Drug Delivery Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Biopharmaceutical Oral Drug Delivery Product Offered
13.1.3 AbbVie Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Biopharmaceutical Oral Drug Delivery Product Offered
13.2.3 Amgen Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Catalent
13.3.1 Catalent Company Information
13.3.2 Catalent Biopharmaceutical Oral Drug Delivery Product Offered
13.3.3 Catalent Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Catalent Main Business Overview
13.3.5 Catalent Latest Developments
13.4 Kemwell Bipharma
13.4.1 Kemwell Bipharma Company Information
13.4.2 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Offered
13.4.3 Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kemwell Bipharma Main Business Overview
13.4.5 Kemwell Bipharma Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Biopharmaceutical Oral Drug Delivery Product Offered
13.5.3 Pfizer Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Biopharmaceutical Oral Drug Delivery Product Offered
13.6.3 Novartis Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Biopharmaceutical Oral Drug Delivery Product Offered
13.7.3 Biocon Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Biopharmaceutical Oral Drug Delivery Product Offered
13.8.3 Sanofi Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 F. Hoffman-La Roche
13.9.1 F. Hoffman-La Roche Company Information
13.9.2 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Offered
13.9.3 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 F. Hoffman-La Roche Main Business Overview
13.9.5 F. Hoffman-La Roche Latest Developments
13.10 Novo Nordisk
13.10.1 Novo Nordisk Company Information
13.10.2 Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Offered
13.10.3 Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novo Nordisk Main Business Overview
13.10.5 Novo Nordisk Latest Developments
14 Research Findings and Conclusion
Table 1. Biopharmaceutical Oral Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biopharmaceutical Oral Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Normally Protein (Antibodies)
Table 4. Major Players of Nucleic Acids (DNA, RNA Or Oligonucleotides)
Table 5. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 6. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 7. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2017-2022) & ($ million)
Table 8. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2022)
Table 9. Global Biopharmaceutical Oral Drug Delivery Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 11. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 12. Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2017-2022)
Table 13. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2017-2022)
Table 14. Global Biopharmaceutical Oral Drug Delivery Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Biopharmaceutical Oral Drug Delivery Sales by Company (2020-2022) & (K Units)
Table 16. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Company (2020-2022)
Table 17. Global Biopharmaceutical Oral Drug Delivery Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Company (2020-2022)
Table 19. Global Biopharmaceutical Oral Drug Delivery Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Biopharmaceutical Oral Drug Delivery Producing Area Distribution and Sales Area
Table 21. Players Biopharmaceutical Oral Drug Delivery Products Offered
Table 22. Biopharmaceutical Oral Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biopharmaceutical Oral Drug Delivery Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Biopharmaceutical Oral Drug Delivery Sales Market Share Geographic Region (2017-2022)
Table 27. Global Biopharmaceutical Oral Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Biopharmaceutical Oral Drug Delivery Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Country/Region (2017-2022)
Table 31. Global Biopharmaceutical Oral Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 34. Americas Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2017-2022)
Table 35. Americas Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2017-2022)
Table 37. Americas Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 38. Americas Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 39. Americas Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 40. Americas Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 41. APAC Biopharmaceutical Oral Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 42. APAC Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2017-2022)
Table 43. APAC Biopharmaceutical Oral Drug Delivery Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2017-2022)
Table 45. APAC Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 46. APAC Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 47. APAC Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 48. APAC Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 49. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 50. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2017-2022)
Table 51. Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2017-2022)
Table 53. Europe Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 54. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 55. Europe Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 56. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Biopharmaceutical Oral Drug Delivery
Table 66. Key Market Challenges & Risks of Biopharmaceutical Oral Drug Delivery
Table 67. Key Industry Trends of Biopharmaceutical Oral Drug Delivery
Table 68. Biopharmaceutical Oral Drug Delivery Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Biopharmaceutical Oral Drug Delivery Distributors List
Table 71. Biopharmaceutical Oral Drug Delivery Customer List
Table 72. Global Biopharmaceutical Oral Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Biopharmaceutical Oral Drug Delivery Sales Market Forecast by Region
Table 74. Global Biopharmaceutical Oral Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Biopharmaceutical Oral Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Biopharmaceutical Oral Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Biopharmaceutical Oral Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Biopharmaceutical Oral Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Biopharmaceutical Oral Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Biopharmaceutical Oral Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Biopharmaceutical Oral Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Biopharmaceutical Oral Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Biopharmaceutical Oral Drug Delivery Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Biopharmaceutical Oral Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Biopharmaceutical Oral Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Biopharmaceutical Oral Drug Delivery Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Biopharmaceutical Oral Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
Table 92. AbbVie Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 93. AbbVie Biopharmaceutical Oral Drug Delivery Product Offered
Table 94. AbbVie Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. AbbVie Main Business
Table 96. AbbVie Latest Developments
Table 97. Amgen Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 98. Amgen Biopharmaceutical Oral Drug Delivery Product Offered
Table 99. Amgen Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Amgen Main Business
Table 101. Amgen Latest Developments
Table 102. Catalent Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 103. Catalent Biopharmaceutical Oral Drug Delivery Product Offered
Table 104. Catalent Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Catalent Main Business
Table 106. Catalent Latest Developments
Table 107. Kemwell Bipharma Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 108. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Product Offered
Table 109. Kemwell Bipharma Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Kemwell Bipharma Main Business
Table 111. Kemwell Bipharma Latest Developments
Table 112. Pfizer Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Biopharmaceutical Oral Drug Delivery Product Offered
Table 114. Pfizer Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Novartis Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Biopharmaceutical Oral Drug Delivery Product Offered
Table 119. Novartis Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Biocon Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 123. Biocon Biopharmaceutical Oral Drug Delivery Product Offered
Table 124. Biocon Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Biocon Main Business
Table 126. Biocon Latest Developments
Table 127. Sanofi Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 128. Sanofi Biopharmaceutical Oral Drug Delivery Product Offered
Table 129. Sanofi Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Sanofi Main Business
Table 131. Sanofi Latest Developments
Table 132. F. Hoffman-La Roche Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 133. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Product Offered
Table 134. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. F. Hoffman-La Roche Main Business
Table 136. F. Hoffman-La Roche Latest Developments
Table 137. Novo Nordisk Basic Information, Biopharmaceutical Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 138. Novo Nordisk Biopharmaceutical Oral Drug Delivery Product Offered
Table 139. Novo Nordisk Biopharmaceutical Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Novo Nordisk Main Business
Table 141. Novo Nordisk Latest Developments
List of Figures
Figure 1. Picture of Biopharmaceutical Oral Drug Delivery
Figure 2. Biopharmaceutical Oral Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biopharmaceutical Oral Drug Delivery Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Biopharmaceutical Oral Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biopharmaceutical Oral Drug Delivery Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Normally Protein (Antibodies)
Figure 10. Product Picture of Nucleic Acids (DNA, RNA Or Oligonucleotides)
Figure 11. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type in 2021
Figure 12. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2017-2022)
Figure 13. Biopharmaceutical Oral Drug Delivery Consumed in Hospital Pharmacy
Figure 14. Global Biopharmaceutical Oral Drug Delivery Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 15. Biopharmaceutical Oral Drug Delivery Consumed in Retail Pharmacy
Figure 16. Global Biopharmaceutical Oral Drug Delivery Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 17. Biopharmaceutical Oral Drug Delivery Consumed in Specialty Pharmacy
Figure 18. Global Biopharmaceutical Oral Drug Delivery Market: Specialty Pharmacy (2017-2022) & (K Units)
Figure 19. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2017-2022)
Figure 20. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application in 2021
Figure 21. Biopharmaceutical Oral Drug Delivery Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Company in 2021
Figure 23. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Geographic Region in 2021
Figure 25. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2017-2022)
Figure 26. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country/Region in 2021
Figure 27. Americas Biopharmaceutical Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 28. Americas Biopharmaceutical Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 29. APAC Biopharmaceutical Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 30. APAC Biopharmaceutical Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 31. Europe Biopharmaceutical Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 32. Europe Biopharmaceutical Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Biopharmaceutical Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 35. Americas Biopharmaceutical Oral Drug Delivery Sales Market Share by Country in 2021
Figure 36. Americas Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country in 2021
Figure 37. United States Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Biopharmaceutical Oral Drug Delivery Sales Market Share by Region in 2021
Figure 42. APAC Biopharmaceutical Oral Drug Delivery Revenue Market Share by Regions in 2021
Figure 43. China Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Country in 2021
Figure 50. Europe Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country in 2021
Figure 51. Germany Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country in 2021
Figure 58. Egypt Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Biopharmaceutical Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Biopharmaceutical Oral Drug Delivery in 2021
Figure 64. Manufacturing Process Analysis of Biopharmaceutical Oral Drug Delivery
Figure 65. Industry Chain Structure of Biopharmaceutical Oral Drug Delivery
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...